Vol. 289, Issue 1, 261-265, April 1999

Human Endothelin-1 Clearance Kinetics Revealed by a Radiotracer Technique

John D. Parker , Jake J. Thiessen¹, Ray Reilly², Jeffrey H. Tong³, Duncan J. Stewart⁴ and A. Shekhar Pandey

Division of Cardiology, Mount Sinai Hospital (J.D.P., A.S.P.) and Department of Medicine, University of Toronto (J.D.P., D.J.S., A.S.P.), Ontario, Canada

Levels of endothelin-1 (ET-1) are elevated in many disease states, although its total body kinetics of elimination are poorly understood. Therefore, it remains uncertain whether the presence of elevated levels of ET-1 in the setting of disease are secondary to changes in production or clearance or some combination thereof. Using a ¹²⁵I-labeled ET-1 infusion technique, the volume of distribution and kinetics of clearance of endothelin were described in five normal volunteers. Heart rate, blood pressure, right atrial pressure, and arterial blood samples for the counting of ¹²⁵I and the measurement of ET-1 were obtained at multiple time points before and up to 45 h after the start of the infusion. The radiotracer infusion had no effect on heart rate, blood pressure, right atrial pressure, or endogenous ET-1 levels. ET-1 clearance was best described by a three-compartment model, which revealed that ET-1 has a much longer terminal half-life and volume of distribution than was previously reported. This suggests extensive uptake of ET-1 in various organ systems and slow clearance. These new findings have important implications for the understanding of the pathophysiology of ET-1 in disease states as well as for the understanding and development of ET-1 receptor blockers and endothelin-converting enzyme inhibitors.